From: In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin’
Scaffold material | Cell lines and/or other components | MI model | Main results | References |
---|---|---|---|---|
Chitosan | Rat brown ATDSCs | Rat | Cell survival and retention↑, EF↑, FS↑, LV end-diastolic pressure↓, LV pressure change↑, infarct size↓, fibrosis↓, ATDSC to cardiac lineage differentiation↑, vessel density↑, endothelial and smooth muscle cell differentiation | [81] |
 | Mouse ESCs | Rat | Infarct zone cell retention↑, ESC to cardiac differentiation, heart function↑, LV end-diastolic and end-systolic diameters↓, EF↑, FS↑, infarct size↓, wall thickness↑, complete chitosan degradation, microvessel density↑ | [82] |
 | Mouse nuclear-transferred ESCs or fertilization-derived mouse ESC | Rat | For both cell types: infarcted area covered↑, possible differentiation into CMs, smooth muscle cells and ECs, heart function↑, LV end-diastolic and end-systolic diameters↓, EF↑, FS↑, infarct size↓, wall thickness↑, complete chitosan degradation, neovascularization↑ | [83] |
 | bFGF | Rat | LV EF↑, LV FS↑, arteriole density↑, infarct size↓, fibrosis area↓ | [84] |
 | RoY peptide | Rat | Angiogenesis↑, ventricular wall thickness↑, fibrosis↓, infarct size↓, LV FS↑, LV EF↑ | [85] |
Chitosan+alginate | Rat MSCs | Rat | EF↑, LV function↑, angiogenesis↑ | [77] |
 | – | Rat | Angiogenesis↑, no inflammation exacerbation, apoptosis↓, presence of c-kit+ cells↑, proliferation↑, wall thickness↑, LV expansion↓, LV EF↑ | [87] |
Alginate | – | Rat | Absence of arrhythmias or thrombus formation, scaffold degraded, scar thickness↑, diastolic and systolic anterior wall thicknesses↑, LV end-diastolic and systolic dimensions↓, LV end-diastolic and systolic areas↓, cardiac dysfunction↓ | [98] |
 | – | Dog | End-systolic and end-diastolic wall thicknesses↑, LV end-diastolic and systolic volumes↓, end-systolic sphericity index↑, LV EF↑, functional mitral regurgitation↓, LV function↑ | [99] |
 | – | Pig | No arrhythmias or conduction blocks, no remote infarcts in other organs, LV enlargement↓, LV function↑, coronary blood flow not affected, scar thickness↑, anterior wall thickness↑ | [100] |
 | Rat fetal cardiac cells | Rat | Vascularization↑, formation of myofibers and gap junctions, preservation of LV dimensions and FS | [102] |
 | Human ESCs or human embryonic bodies | Rat | FS↑, LV dilation, absence of inflammation, no cardiomyogenic differentiation, no cell retention | [103] |
 | RGD peptide | Rat | FS↑, LV dimension↓, LV wall thickness↑, angiogenesis↑ | [105] |
 | RGD peptide+encapsulated MSCs (microbeads) | Rat | LV function↑, wall thickness preservation, LV internal dimensions preserved, infarct size↓, angiogenesis↑, high cell retention | [106] |
 | Unmodified alginate; RGD or YIGSR peptide-modified alginate; or RGE peptide-modified alginate | Rat | Unmodified-alginate: scar thickness↑, attenuated LV systolic and diastolic dilatations, LV FS↑, fractional area change↑, LV expansion index↓ (compared with all peptide-modified alginates) | [107] |
 | IGF/HGF (microbeads) | Rat | Scar thickness preservation, infarct expansion index↓, scar collagen accumulation↓, vascularization↑, apoptosis↓ | [110] |
 | – | Human | New York Heart Association functional class↑, Kansas City Cardiomyopathy Questionnaire score↑ | [111] |
Alginate+fibrin | – | Pig | LV posterior wall thickness↑, infarct expansion↓, extractable collagen↓ | [115] |
Alginate+Matrigel+omentum | Neonatal rat cardiac cells with SDF-1, IGF-1 and VEGF | Rat | Mechanical and electrical coupling, relative scar thickness↑, angiogenesis↑, infarct expansion index↓, FS and fractional area change preserved, LV end-diastolic and systolic dimensions↓ | [117] |
Alginate+polypyrrole | – | Rat | No inflammation, angiogenesis↑, myofibroblast population↑ | [118] |
Hyaluronic acid | Alone or with VEGF | Rat | Ventricle thickness↑, infarct size↓, apoptosis↓, vascularization↑, heart function↑ | [121] |
 | Rat BMMNCs | Rat | Apoptosis↓, inflammatory response↓, EF↑, ventricular dilatation↓, scar size↓, collagen content↓, angiogenesis↑, cell differentiation into ECs | [124] |
 | Pig BMMNCs | Pig | LV EF↑, interventricular septum thickness↑, LV end-diastolic pressure and volume↓, contractility↑, scar size and length↓, fibrosis↓, high cell retention, neovascularization↑ | [125] |
 | Rat bone marrow MSCs (esterified hyaluronic acid) | Rat | Construct integration, vascularization↑, fibrosis↓ | [126] |
 | Pig bone marrow MSCs (esterified hyaluronic acid) | Pig | Inflammation↓, fibrosis↓, degeneration of cardiac cells↓ | [127] |
 | Hydroxyethyl methacrylate, SDF-1α, mouse bone marrow cells | Mouse | Cell homing in the myocardium↑ | [128] |
 | rTIMP-3 | Pig | LV end-diastolic dimension↓, LV EF↑, wall stress↓, infarct expansion↓, wall thickness↑, LV end-diastolic volume preserved, myofibroblast number↑, collagen content↑ | [130] |
 | Gelin-S | Rat | LV EF↑, LV FS↑, neovascularization↑, collagen deposition↓ | [131] |
 | Methacrylic anhydride | Sheep | Regional wall thickness↑, infarcted area↓ (only for highly stiff scaffold) | [132] |
 | Methacrylic anhydride or/and hydroxyethylmethacrylate | Sheep | Wall thickness↑, vascularization↑, inflammation↑, LV end-systolic volume↓ (only for highly stiff, stable scaffold) | [133] |
Hyaluronic acid+gelatin | Human cardiosphere-derived cells | Mouse | Cardiac function↑, LV remodeling and abnormal heart morphology↓, viable tissue↑, wall thickness↑, cardiac and endothelial cellular differentiation, cellular engraftment↑, neovascularization↑, apoptosis↓ | [134] |
Hyaluronic acid+silk fibroin | Rat bone marrow MSCs | Rat | LV inner diameter↓, wall thickness↑, FS↑, inflammation↓, apoptosis↓, vascularization↑, α-MHC expression↑, paracrine factor secretion↑ | [135] |
Hyaluronic acid+chitosan+silk fibroin | – | Rat | LV inner diameter↓, wall thickness↑, LV FS↑, angiogenesis↑, paracrine factor expression↑ | [136] |
Hyaluronic acid+butyric and retinoic acids | Human placenta-derived MSCs | Pig | Scar size↓, infarct core zone↓, angiogenesis↑, fibrosis↓, end-systolic wall thickening and circumferential shortening↑, high homology with healthy myocardium | [137] |